Publication | Closed Access

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial

Zoledronic AcidUrologyTrog 03.04Radiation TherapyMedicineFactorial TrialProstatic DiseaseOncologyRadiation Oncology